AU Patent

AU2023358792A1 — Methods of treating cancers using isoquinoline or 6-aza-quinoline derivatives

Assigned to Black Diamond Therapeutics Inc · Expires 2025-04-17 · 1y expired

What this patent protects

The present disclosure relates to methods of treating or preventing cancer using a compound of Formula (0): or a pharmaceutically acceptable salt thereof. The present disclosure also relates to pharmaceutical compositions and pharmaceutical kits suitable for the treatment or prev…

USPTO Abstract

The present disclosure relates to methods of treating or preventing cancer using a compound of Formula (0): or a pharmaceutically acceptable salt thereof. The present disclosure also relates to pharmaceutical compositions and pharmaceutical kits suitable for the treatment or prevention.

Drugs covered by this patent

Patent Metadata

Patent number
AU2023358792A1
Jurisdiction
AU
Classification
—
Expires
2025-04-17
Drug substance claim
No
Drug product claim
No
Assignee
Black Diamond Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.